SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Medical - Drugs >

PRA Health Sciences, Inc. (PRAH)

Add PRAH Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 10/8/2016 1:06:58 PM - Followers: 0 - Board type: Free - Posts Today: 0

PRA Health Sciences, Inc. 4130 ParkLake Avenue Suite 400 Raleigh, NC 27612 United States 919-786-8200 PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development services to the biotechnology and pharmaceutical industries worldwide. The company offers integrated services, such as data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. Its services include a suite of product registration services, such as clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. The company’s services also comprise strategic solutions, including embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services, including Phase I through Phase IIa clinical trials and bioanalytical laboratory services. It conducts clinical trials in the areas of pharmaceutical development, comprising oncology, central nervous system, inflammation, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. The company was founded in 1976 and is headquartered in Raleigh, North Carolina. PRA Health Sciences, Inc. is a subsidiary of KKR PRA Investors L.P.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
PRAH News: Quarterly Report (10-q) 01:58 PM
PRAH News: Current Report Filing (8-k) 04/25/2017 04:02:02 PM
PRAH News: PRA Health Sciences, Inc. Reports First Quarter 2017 Results 04/25/2017 04:00:00 PM
PRAH News: Additional Proxy Soliciting Materials (definitive) (defa14a) 04/21/2017 04:09:39 PM
PRAH News: Proxy Statement (definitive) (def 14a) 04/21/2017 04:06:13 PM
News News Alert: Quarterly Report (10-q) 04/26/2017 01:58:27 PM
#1   PRAH bullish 57.20 stocktrademan 10/08/16 01:06:58 PM